دورية أكاديمية
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
| العنوان: | Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. |
|---|---|
| المؤلفون: | Haddad RI; Dana-Farber/Brigham and Women's Cancer Center., Bischoff L; Vanderbilt-Ingram Cancer Center., Ball D; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins., Bernet V; Mayo Clinic Cancer Center., Blomain E; Stanford Cancer Institute., Busaidy NL; The University of Texas MD Anderson Cancer Center., Campbell M; UC Davis Comprehensive Cancer Center., Dickson P; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center., Duh QY; UCSF Helen Diller Family Comprehensive Cancer Center., Ehya H; Fox Chase Cancer Center., Goldner WS; Fred & Pamela Buffett Cancer Center., Guo T; UC San Diego Moores Cancer Center., Haymart M; University of Michigan Rogel Cancer Center., Holt S; UT Southwestern Simmons Comprehensive Cancer Center., Hunt JP; Huntsman Cancer Institute at the University of Utah., Iagaru A; Stanford Cancer Institute., Kandeel F; City of Hope National Medical Center., Lamonica DM; Roswell Park Comprehensive Cancer Center., Mandel S; Abramson Cancer Center at the University of Pennsylvania., Markovina S; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine., McIver B; Moffitt Cancer Center., Raeburn CD; University of Colorado Cancer Center., Rezaee R; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute., Ridge JA; Fox Chase Cancer Center., Roth MY; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance., Scheri RP; Duke Cancer Institute., Shah JP; Memorial Sloan Kettering Cancer Center., Sipos JA; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute., Sippel R; University of Wisconsin Carbone Cancer Center., Sturgeon C; Robert H. Lurie Comprehensive Cancer Center of Northwestern University., Wang TN; O'Neal Comprehensive Cancer Center at UAB., Wirth LJ; Massachusetts General Hospital Cancer Center., Wong RJ; Memorial Sloan Kettering Cancer Center., Yeh M; UCLA Jonsson Comprehensive Cancer Center; and., Cassara CJ; National Comprehensive Cancer Network., Darlow S; National Comprehensive Cancer Network. |
| المصدر: | Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2022 Aug; Vol. 20 (8), pp. 925-951. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2010- : Cold Spring Harbor, N.Y. : Harborside Press Original Publication: Sudbury, MA : Jones and Bartlett Publishers, c2003- |
| مواضيع طبية MeSH: | Adenocarcinoma*/drug therapy , Iodine*/therapeutic use , Thyroid Carcinoma, Anaplastic* , Thyroid Neoplasms*/diagnosis , Thyroid Neoplasms*/pathology , Thyroid Neoplasms*/therapy, Carcinoma, Neuroendocrine ; Humans ; Iodine Radioisotopes/therapeutic use |
| مستخلص: | Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine therapy in most patients. Surgery is also the main treatment for medullary thyroid carcinoma, and kinase inhibitors may be appropriate for select patients with recurrent or persistent disease that is not resectable. Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. When systemic therapy is indicated, targeted therapy options are preferred. This article describes NCCN recommendations regarding management of medullary thyroid carcinoma and anaplastic thyroid carcinoma, and surgical management of differentiated thyroid carcinoma (papillary, follicular, Hürthle cell carcinoma). |
| المشرفين على المادة: | 0 (Iodine Radioisotopes) 9679TC07X4 (Iodine) |
| SCR Disease Name: | Thyroid cancer, medullary |
| تواريخ الأحداث: | Date Created: 20220810 Date Completed: 20220812 Latest Revision: 20220921 |
| رمز التحديث: | 20221213 |
| DOI: | 10.6004/jnccn.2022.0040 |
| PMID: | 35948029 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1540-1413 |
|---|---|
| DOI: | 10.6004/jnccn.2022.0040 |